12/7/2007

Patients with adult-onset diabetes were able to lower their blood sugar levels after receiving only Amylin Pharmaceuticals' drug Byetta, a clinical trial showed. The company plans to use the trial results in its FDA application for use of Byetta as a stand-alone therapy.

Related Summaries